jCyte, Inc.
PrivateLast Round
Convertible Debt
May 8, 2020
Total Funding Raised
$47.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
jCyte, Inc. is a drug discovery company that develops cell-based therapeutics intended to cure degenerative retinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
jCyte, Inc. Comparables
Compare jCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InGel Therapeutics | 83% | |
| Nanoscope Therapeutics Inc. | 83% | |
| SparingVision | 81% |
jCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 8, 2020 | ||||
| Grant | Apr 13, 2020 | ||||
| Series A | Apr 1, 2019 | ||||
| Grant | Dec 13, 2016 | ||||
| Grant | Sep 17, 2012 |
Key People
Founding team and executive leadership
jCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 36% of headcount.
- Jan 19, 2026
Monthly visitors grew 63% MoM, reaching 2.5K.
jCyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about jCyte, Inc.'s valuation, stock price, and market status.
Is jCyte, Inc. a public or private company?
jCyte, Inc. is a private company.
What is the current stock price of jCyte, Inc.?
jCyte, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is jCyte, Inc. worth (valuation)?
Valuation information for jCyte, Inc. is not publicly available.
Can I buy jCyte, Inc. stock?
jCyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was jCyte, Inc.'s last funding round?
jCyte, Inc.'s most recent funding round was Convertible Debt on May 8, 2020.
Who are the main investors in jCyte, Inc.?
Key investors in jCyte, Inc. include California Institute for Regenerative Medicine.
Will jCyte, Inc. IPO soon?
No public IPO plans have been announced for jCyte, Inc..
How can I track jCyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor jCyte, Inc.'s secondary market activity and sign up for updates.